Dean Bitan

Imagene AI Ltd. is a precision oncology diagnosis company based in Israel. Imagene AI's molecular and micro-environment intelligence platform provides real-time biomarker reports using only digitized biopsy images, resulting in faster diagnosis and better identification of treatment for cancer patients. The Israeli company aims to bring accurate, fast, accessible, actionable, standardized, and routine diagnosis to all cancer patients and become the standard for making treatment decisions. The company was founded in 2020 by Jonathan Zalach, Dean Bitan, and Shahar Porat, with Dean Bitan serving as the CEO since then.

Imagene AI Ltd. is a precision oncology diagnosis company based in Israel. Imagene AI's molecular and micro-environment intelligence platform provides real-time biomarker reports using only digitized biopsy images, resulting in faster diagnosis and better identification of treatment for cancer patients. The Israeli company aims to bring accurate, fast, accessible, actionable, standardized, and routine diagnosis to all cancer patients and become the standard for making treatment decisions. The company was founded in 2020 by Jonathan Zalach, Dean Bitan, and Shahar Porat, with Dean Bitan serving as the CEO since then.